Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease

OBJECTIVE: Serum biomarkers may serve to predict early response to therapy, identify relapse, and facilitate drug development in inflammatory bowel disease (IBD). Biomarkers are particularly important in children, in whom achieving early remission and minimizing procedures are especially beneficial....

Descripción completa

Detalles Bibliográficos
Autores principales: Heier, Christopher R, Fiorillo, Alyson A, Chaisson, Ellen, Gordish-Dressman, Heather, Hathout, Yetrib, Damsker, Jesse M, Hoffman, Eric P, Conklin, Laurie S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288595/
https://www.ncbi.nlm.nih.gov/pubmed/27628422
http://dx.doi.org/10.1038/ctg.2016.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288595/
https://www.ncbi.nlm.nih.gov/pubmed/27628422
http://dx.doi.org/10.1038/ctg.2016.49

Ejemplares similares